PacBio (PACB) announced that the National Institute on Aging’s Long Life Family Study, LLFS, selected PacBio technology to generate comprehensive genomic and epigenomic data from as many as 7,800 participants. “Long-read HiFi sequencing gives us the accuracy and resolution to see variants and methylation patterns missed by other technologies,” said Dr. Michael Province, Professor at Washington University School of Medicine in St. Louis and contact Principal Investigator of the project. “By generating comprehensive genomes and epigenomes from extended pedigrees with multiple family members living to exceptional ages in LLFS, we expect to sharpen our ability to pinpoint pathways that influence healthy aging and exceptional longevity.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PACB:
- PacBio expands partnership with seqWell
- PacBio announces entry into high-throughput carrier screening market
- PacBio, EpiCypher partner to deliver new insights into epigenomics
- Cathie Wood Pours Over $46M into Biotech Stocks, 8/19/2025
- Pacific Biosciences’ Earnings Call Highlights Growth and Challenges